The focus of the symposium will be on Immuno-Oncology with the following international speakers. Inger Andersson, Chairman of IVA’s Biotechnology – Introduction Professor Kjell Strandberg, former DG MPA – What is immune oncology? Magnus Jäderberg, CMO Targovax, London – The new cancer drugs in a clinical perspective Professor Peter Nygren, Department of Oncology, University Hospital, Uppsala – Faster approvals […]
Contact us >
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.